Comparison
21q22 11q22 12 Microdeletion Syndrome C5192593 vs 16p11 2p12 2 Microduplication Syndrome C4518821
Clinical comparison between 21q22 11q22 12 Microdeletion Syndrome and 16p11 2p12 2 Microduplication Syndrome for differential diagnosis and treatment planning.
21q22 11q22 12 Microdeletion Syndrome C5192593
A rare genetic condition involving deletion of a specific region on chromosome 21. It may cause developmental delay, intellectual disability, and distinctive facial features. Management focuses on developmental support and medical monitoring.
16p11 2p12 2 Microduplication Syndrome C4518821
A rare genetic condition involving extra genetic material on chromosome 16. It may affect development and be associated with developmental delays, learning difficulties, and distinctive features in some individuals. Management involves supportive therapies.
6 comparison axes
Onset
21q22 11q22 12 Microdeletion Syndrome C5192593
0-0
16p11 2p12 2 Microduplication Syndrome C4518821
0-null
Onset patterns differ
Severity
21q22 11q22 12 Microdeletion Syndrome C5192593
severe
16p11 2p12 2 Microduplication Syndrome C4518821
moderate
Different severity levels
Chronic
21q22 11q22 12 Microdeletion Syndrome C5192593
Chronic
16p11 2p12 2 Microduplication Syndrome C4518821
Chronic
Differing course
Communicable
21q22 11q22 12 Microdeletion Syndrome C5192593
No
16p11 2p12 2 Microduplication Syndrome C4518821
No
Different transmission
Body System
21q22 11q22 12 Microdeletion Syndrome C5192593
congenital
16p11 2p12 2 Microduplication Syndrome C4518821
congenital
Same/different system
Category
21q22 11q22 12 Microdeletion Syndrome C5192593
rare-disease
16p11 2p12 2 Microduplication Syndrome C4518821
genetic
Different category
Bottom line
21q22-11q22-12-microdeletion-syndrome-C5192593 and 16p11-2p12-2-microduplication-syndrome-C4518821 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 16p11 2p12 2 Microduplication Syndrome C4518821 | Discriminating power |
|---|---|---|---|
| Chromosomal change | Deletion involving a chromosome 21 region | Extra genetic material on chromosome 16 | High |
| Development | May include developmental delay and intellectual disability | May include developmental delay and learning difficulties | Low |
| Reported severity | Source severity label is severe | Source severity label is moderate | Moderate |
When to favor each condition
Choose 21q22 11q22 12 Microdeletion Syndrome C5192593 when
Confirmed chromosome 21 deletion
The genetic result directly matches this condition
High
Need for broad medical monitoring
Management emphasizes developmental support and monitoring
Moderate
Severe-appearing presentation alone
Severity suggests but does not establish the diagnosis
Low
Choose 16p11 2p12 2 Microduplication Syndrome C4518821 when
Confirmed chromosome 16 duplication
The genetic result directly matches this condition
High
Learning-focused support needs
Supportive therapies may address learning difficulties
Moderate
Moderate developmental concerns alone
Clinical severity cannot reliably distinguish the syndromes
Low
How key tests differ
| Test | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 16p11 2p12 2 Microduplication Syndrome C4518821 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Deletion in the relevant chromosome 21 region if confirmed | Duplication in the relevant chromosome 16 region if confirmed | Best supplied method for distinguishing the copy-number changes |
| Karyotype | A small deletion may not be visible | A small duplication may not be visible | A normal result does not exclude either condition |
| Developmental assessment | Delay or intellectual disability may be documented | Delay or learning difficulty may be documented | Findings overlap and are not diagnostic |
Prognosis comparison
21q22 11q22 12 Microdeletion Syndrome C5192593
- Outcome
- Long-term outcome is not established; substantial developmental impact may occur.
- Factors
- Deletion details, associated findings, and available support may influence outcome.
16p11 2p12 2 Microduplication Syndrome C4518821
- Outcome
- Long-term outcome is not established; developmental or learning effects may vary.
- Factors
- Duplication details, comorbidities, and educational support may influence outcome.
Time frame: Both are described as chronic, but precise milestones are not established.
Individual genetic results and clinical findings should guide prognosis.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental delay | Possible and potentially substantial Possible, with variable extent Exact frequency and severity are not established here |
| Learning or intellectual difficulty | Intellectual disability may occur Learning difficulties may occur Assessment should be individualized |
| Associated medical problems | Specific complications are not established Specific complications are not established Clinicians should monitor according to findings |
Patient education highlights
- HighDiagnosis
Features overlap; only appropriate genetic testing can distinguish these conditions.
- HighInheritance counseling
Neither condition is communicable. Recurrence risk requires genetic counseling.
- MediumSupport
Therapies and educational support are tailored; no dose or treatment protocol is established here.